The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Vivo Biosafety Testing Services Market Research Report 2025

Global In Vivo Biosafety Testing Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735983

No of Pages : 92

Ask Your Query

Synopsis
Global In Vivo Biosafety Testing Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vivo Biosafety Testing Services market research.
Key manufacturers engaged in the In Vivo Biosafety Testing Services industry include Toyobo Co. Ltd, Charles River Laboratories Inc., Lonza Group, Avance Biosciences Inc., BSL BIOSERVICE Scientific Laboratories Munich GmbH, SGS S.A., Toxikon Corporation, Sartorius Stedim BioOutsource Ltd. and Merck KGaA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of In Vivo Biosafety Testing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Vivo Biosafety Testing Services market and estimated to attract more attentions from industry insiders and investors.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global In Vivo Biosafety Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Toyobo Co. Ltd
  • Charles River Laboratories Inc.
  • Lonza Group
  • Avance Biosciences Inc.
  • BSL BIOSERVICE Scientific Laboratories Munich GmbH
  • SGS S.A.
  • Toxikon Corporation
  • Sartorius Stedim BioOutsource Ltd.
  • Merck KGaA
  • WuXi Biologics
  • Shenzhen Hepalink Pharmaceutical Co., Ltd

Segment by Type

  • Antibody Production Experiment
  • Exogenous Factor Detection
  • Biological Product Safety Testing
  • Tumorigenicity Detection

Segment by Application

  • Hospital
  • Clinic
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The In Vivo Biosafety Testing Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global In Vivo Biosafety Testing Services Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global In Vivo Biosafety Testing Services Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global In Vivo Biosafety Testing Services Market Competitive Situation by Manufacturers in 2022
Table 4. Global In Vivo Biosafety Testing Services Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global In Vivo Biosafety Testing Services Sales Market Share by Manufacturers (2018-2023)
Table 6. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global In Vivo Biosafety Testing Services Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market In Vivo Biosafety Testing Services Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of In Vivo Biosafety Testing Services, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of In Vivo Biosafety Testing Services, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of In Vivo Biosafety Testing Services, Product Type & Application
Table 12. Global Key Manufacturers of In Vivo Biosafety Testing Services, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global In Vivo Biosafety Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Biosafety Testing Services as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global In Vivo Biosafety Testing Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global In Vivo Biosafety Testing Services Sales by Region (2018-2023) & (K Units)
Table 18. Global In Vivo Biosafety Testing Services Sales Market Share by Region (2018-2023)
Table 19. Global In Vivo Biosafety Testing Services Sales by Region (2024-2029) & (K Units)
Table 20. Global In Vivo Biosafety Testing Services Sales Market Share by Region (2024-2029)
Table 21. Global In Vivo Biosafety Testing Services Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global In Vivo Biosafety Testing Services Revenue Market Share by Region (2018-2023)
Table 23. Global In Vivo Biosafety Testing Services Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global In Vivo Biosafety Testing Services Revenue Market Share by Region (2024-2029)
Table 25. North America In Vivo Biosafety Testing Services Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America In Vivo Biosafety Testing Services Sales by Country (2018-2023) & (K Units)
Table 27. North America In Vivo Biosafety Testing Services Sales by Country (2024-2029) & (K Units)
Table 28. North America In Vivo Biosafety Testing Services Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America In Vivo Biosafety Testing Services Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe In Vivo Biosafety Testing Services Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe In Vivo Biosafety Testing Services Sales by Country (2018-2023) & (K Units)
Table 32. Europe In Vivo Biosafety Testing Services Sales by Country (2024-2029) & (K Units)
Table 33. Europe In Vivo Biosafety Testing Services Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe In Vivo Biosafety Testing Services Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific In Vivo Biosafety Testing Services Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific In Vivo Biosafety Testing Services Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America In Vivo Biosafety Testing Services Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America In Vivo Biosafety Testing Services Sales by Country (2018-2023) & (K Units)
Table 42. Latin America In Vivo Biosafety Testing Services Sales by Country (2024-2029) & (K Units)
Table 43. Latin America In Vivo Biosafety Testing Services Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America In Vivo Biosafety Testing Services Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa In Vivo Biosafety Testing Services Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa In Vivo Biosafety Testing Services Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global In Vivo Biosafety Testing Services Sales (K Units) by Type (2018-2023)
Table 51. Global In Vivo Biosafety Testing Services Sales (K Units) by Type (2024-2029)
Table 52. Global In Vivo Biosafety Testing Services Sales Market Share by Type (2018-2023)
Table 53. Global In Vivo Biosafety Testing Services Sales Market Share by Type (2024-2029)
Table 54. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Type (2018-2023)
Table 55. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Type (2024-2029)
Table 56. Global In Vivo Biosafety Testing Services Revenue Market Share by Type (2018-2023)
Table 57. Global In Vivo Biosafety Testing Services Revenue Market Share by Type (2024-2029)
Table 58. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2018-2023)
Table 59. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2024-2029)
Table 60. Global In Vivo Biosafety Testing Services Sales (K Units) by Application (2018-2023)
Table 61. Global In Vivo Biosafety Testing Services Sales (K Units) by Application (2024-2029)
Table 62. Global In Vivo Biosafety Testing Services Sales Market Share by Application (2018-2023)
Table 63. Global In Vivo Biosafety Testing Services Sales Market Share by Application (2024-2029)
Table 64. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Application (2018-2023)
Table 65. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Application (2024-2029)
Table 66. Global In Vivo Biosafety Testing Services Revenue Market Share by Application (2018-2023)
Table 67. Global In Vivo Biosafety Testing Services Revenue Market Share by Application (2024-2029)
Table 68. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2018-2023)
Table 69. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2024-2029)
Table 70. Toyobo Co. Ltd Corporation Information
Table 71. Toyobo Co. Ltd Description and Business Overview
Table 72. Toyobo Co. Ltd In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Toyobo Co. Ltd In Vivo Biosafety Testing Services Product
Table 74. Toyobo Co. Ltd Recent Developments/Updates
Table 75. Charles River Laboratories Inc. Corporation Information
Table 76. Charles River Laboratories Inc. Description and Business Overview
Table 77. Charles River Laboratories Inc. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Charles River Laboratories Inc. In Vivo Biosafety Testing Services Product
Table 79. Charles River Laboratories Inc. Recent Developments/Updates
Table 80. Lonza Group Corporation Information
Table 81. Lonza Group Description and Business Overview
Table 82. Lonza Group In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Lonza Group In Vivo Biosafety Testing Services Product
Table 84. Lonza Group Recent Developments/Updates
Table 85. Avance Biosciences Inc. Corporation Information
Table 86. Avance Biosciences Inc. Description and Business Overview
Table 87. Avance Biosciences Inc. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Avance Biosciences Inc. In Vivo Biosafety Testing Services Product
Table 89. Avance Biosciences Inc. Recent Developments/Updates
Table 90. BSL BIOSERVICE Scientific Laboratories Munich GmbH Corporation Information
Table 91. BSL BIOSERVICE Scientific Laboratories Munich GmbH Description and Business Overview
Table 92. BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Product
Table 94. BSL BIOSERVICE Scientific Laboratories Munich GmbH Recent Developments/Updates
Table 95. SGS S.A. Corporation Information
Table 96. SGS S.A. Description and Business Overview
Table 97. SGS S.A. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. SGS S.A. In Vivo Biosafety Testing Services Product
Table 99. SGS S.A. Recent Developments/Updates
Table 100. Toxikon Corporation Corporation Information
Table 101. Toxikon Corporation Description and Business Overview
Table 102. Toxikon Corporation In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Toxikon Corporation In Vivo Biosafety Testing Services Product
Table 104. Toxikon Corporation Recent Developments/Updates
Table 105. Sartorius Stedim BioOutsource Ltd. Corporation Information
Table 106. Sartorius Stedim BioOutsource Ltd. Description and Business Overview
Table 107. Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Product
Table 109. Sartorius Stedim BioOutsource Ltd. Recent Developments/Updates
Table 110. Merck KGaA Corporation Information
Table 111. Merck KGaA Description and Business Overview
Table 112. Merck KGaA In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Merck KGaA In Vivo Biosafety Testing Services Product
Table 114. Merck KGaA Recent Developments/Updates
Table 115. WuXi Biologics Corporation Information
Table 116. WuXi Biologics Description and Business Overview
Table 117. WuXi Biologics In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. WuXi Biologics In Vivo Biosafety Testing Services Product
Table 119. WuXi Biologics Recent Developments/Updates
Table 120. Shenzhen Hepalink Pharmaceutical Co., Ltd Corporation Information
Table 121. Shenzhen Hepalink Pharmaceutical Co., Ltd Description and Business Overview
Table 122. Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Product
Table 124. Shenzhen Hepalink Pharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. In Vivo Biosafety Testing Services Distributors List
Table 128. In Vivo Biosafety Testing Services Customers List
Table 129. In Vivo Biosafety Testing Services Market Trends
Table 130. In Vivo Biosafety Testing Services Market Drivers
Table 131. In Vivo Biosafety Testing Services Market Challenges
Table 132. In Vivo Biosafety Testing Services Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of In Vivo Biosafety Testing Services
Figure 2. Global In Vivo Biosafety Testing Services Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global In Vivo Biosafety Testing Services Market Share by Type in 2022 & 2029
Figure 4. Antibody Production Experiment Product Picture
Figure 5. Exogenous Factor Detection Product Picture
Figure 6. Biological Product Safety Testing Product Picture
Figure 7. Tumorigenicity Detection Product Picture
Figure 8. Global In Vivo Biosafety Testing Services Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global In Vivo Biosafety Testing Services Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global In Vivo Biosafety Testing Services Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global In Vivo Biosafety Testing Services Market Size (2018-2029) & (US$ Million)
Figure 15. Global In Vivo Biosafety Testing Services Sales (2018-2029) & (K Units)
Figure 16. Global In Vivo Biosafety Testing Services Average Price (US$/Unit) & (2018-2029)
Figure 17. In Vivo Biosafety Testing Services Report Years Considered
Figure 18. In Vivo Biosafety Testing Services Sales Share by Manufacturers in 2022
Figure 19. Global In Vivo Biosafety Testing Services Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest In Vivo Biosafety Testing Services Players: Market Share by Revenue in 2022
Figure 21. In Vivo Biosafety Testing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global In Vivo Biosafety Testing Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America In Vivo Biosafety Testing Services Sales Market Share by Country (2018-2029)
Figure 24. North America In Vivo Biosafety Testing Services Revenue Market Share by Country (2018-2029)
Figure 25. United States In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe In Vivo Biosafety Testing Services Sales Market Share by Country (2018-2029)
Figure 28. Europe In Vivo Biosafety Testing Services Revenue Market Share by Country (2018-2029)
Figure 29. Germany In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific In Vivo Biosafety Testing Services Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific In Vivo Biosafety Testing Services Revenue Market Share by Region (2018-2029)
Figure 36. China In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America In Vivo Biosafety Testing Services Sales Market Share by Country (2018-2029)
Figure 44. Latin America In Vivo Biosafety Testing Services Revenue Market Share by Country (2018-2029)
Figure 45. Mexico In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Colombia In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa In Vivo Biosafety Testing Services Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa In Vivo Biosafety Testing Services Revenue Market Share by Country (2018-2029)
Figure 51. Turkey In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE In Vivo Biosafety Testing Services Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of In Vivo Biosafety Testing Services by Type (2018-2029)
Figure 55. Global Revenue Market Share of In Vivo Biosafety Testing Services by Type (2018-2029)
Figure 56. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of In Vivo Biosafety Testing Services by Application (2018-2029)
Figure 58. Global Revenue Market Share of In Vivo Biosafety Testing Services by Application (2018-2029)
Figure 59. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2018-2029)
Figure 60. In Vivo Biosafety Testing Services Value Chain
Figure 61. In Vivo Biosafety Testing Services Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock